Tag: Dividend Investing

Disney Continues To Deliver Robust Growth

Posted on by Noah Kiedrowski

Noah Kiedrowski - INO.com Contributor - Biotech


I recently wrote two articles highlighting Disney as an inexpensive growth opportunity for long-term investors. In my opinion, Disney presents a compelling case for long-term investors. My positive sentiment is rooted in many lucrative franchises such as Star Wars, Pixar, Marvel, ESPN and the legacy Disney brand turning out original content such as Frozen and more recently Zootopia. Disney offers a deep and well-diversified product portfolio that is set to provide growth, income and safety well into the future. This portfolio gives rise to a basket of entertainment income streams via movies, licensing deals, theme parks, TV programing, resorts and distribution rights. Disney stock has been under pressure as of late due to increasingly worrisome revenue declines from its ESPN franchise. I feel this decline in the stock is unwarranted, and analysts underestimate the ability of Disney to evolve to the consumer and monetize ESPN via other means. My views were recently echoed by analysts at Pivotal Research which upgraded the stock from a hold to a buy and raised its target price from $104 to $122. JPMorgan Chase also reiterated its buy rating and assigned a $118 target price. Disney has witnessed fantastic growth over the last decade and considering future catalysts in the pipeline; Disney appears undervalued. Disney currently sits at a P/E of ~18 along with a PEG of ~1.5 and has seen its stock fall from $122 to a current price of ~$98 or alternatively a 20% decline. Taking a look at its P/E ratio (currently 18 – in-line with the broader market average) indicates that it’s an average stock and I believe Disney is much more than the average stock. This presents a great buying opportunity in an inexpensive, high-quality growth stock. Continue reading "Disney Continues To Deliver Robust Growth" →

Are Hasbro Results A Harbinger For Disney Earnings?

Posted on by Noah Kiedrowski

Noah Kiedrowski - INO.com Contributor - Biotech


I recently wrote a piece highlighting Disney as an inexpensive growth opportunity for long-term investors. My positive sentiment was rooted in many lucrative franchises such as Star Wars, Pixar, Marvel, ESPN and the legacy Disney brand turning out original content such as Frozen and Zootopia. Disney offers a deep and well-diversified product portfolio that is set to provide growth and safety well into the future. This portfolio gives rise to a basket of entertainment income streams via movies, licensing deals, theme parks, TV programing, resorts and distribution rights. Disney stock has been under pressure as of late due to increasingly worrisome revenue declines from the ESPN franchise. I felt this decline in the stock is unwarranted, and analysts underestimate the ability of Disney to evolve to the consumer and monetize ESPN via other means. My views were recently echoed by analysts at Pivotal Research which upgraded the stock from a hold to a buy and raised its target price from $104 to $122. JPMorgan Chase also reiterated its buy rating and a $118 target price. Disney has witnessed fantastic growth over the last decade and considering future catalysts in the pipeline; Disney appears undervalued. Disney currently sits at a P/E of ~18 along with a PEG of ~1.5 and has seen its stock fall from $122 to a current price of ~$100 or alternatively a ~20% decline. This presents a great buying opportunity in an inexpensive, high-quality growth stock.

Are Hasbro Results A Harbinger for Upcoming Disney Earnings?

Disney and Hasbro have established a mutually beneficial partnership as Hasbro’s recent quarterly sales increased by 16%. This double-digit increase in sales was largely attributable to the sales of Disney’s Star Wars and Princess franchises. Overall, Hasbro’s revenue grew to $831.2 million from $713.5 million during a time that is typically slower for toy makers. Hasbro’s strong numbers benefited from the late 2015 release of the new Star Wars film. CEO Brian Goldner stated “Retail and consumer demand for Star Wars remained very high” and that Hasbro’s line of Disney Princess characters was “very positive.” The Disney and Hasbro relationship is being leveraged for future movies such as the upcoming Captain America Civil War film as well. Continue reading "Are Hasbro Results A Harbinger For Disney Earnings?" →

Disney - A Very Attractive Inexpensive Growth Stock

Posted on by Noah Kiedrowski

Noah Kiedrowski - INO.com Contributor - Biotech


Disney offers an array of world renowned franchises (Star Wars, Pixar, Marvel, ESPN and the Disney offerings) that offer a deep and well-diversified product portfolio. This portfolio gives rise to a basket of entertainment income streams via movies, licensing deals, theme parks, TV programing, resorts and distribution rights. Disney stock has been under pressure as of late due to increasingly worrisome revenue declines from the ESPN franchise. I feel this decline in the stock is unwarranted and analysts underestimate the ability of Disney to evolve to the consumer and monetize ESPN via other means. The generational penetration of the Star Wars, Marvel, Pixar and the legacy Disney franchises are being underestimated and undervalued. Disney has witnessed fantastic growth over the last decade and considering future catalysts in the pipeline; Disney appears undervalued. Disney currently sits at a P/E of 18 along with a PEG of 1.5 and has seen its stock fall from $122 to a current price of $96 or alternatively a 21% decline. This presents a great buying opportunity in an inexpensive, high-quality growth stock.

Future Growth and Pipeline

Disney has a rich pipeline with Star Wars themed parks, Star Wars movies, the opening of Disney Shanghai, Marvel movies, Pixar movies and future Disney movies such as Finding Dory to highlight a few. The deep movie portfolio and distribution schedule is highlighted below (Figure 1). Continue reading "Disney - A Very Attractive Inexpensive Growth Stock" →

CVS Boosts Dividend By 21% And Raises 2016 Outlook

Posted on by Noah Kiedrowski

Noah Kiedrowski - INO.com Contributor - Biotech


Introduction

I have posted that CVS presented a compelling investment opportunity in the healthcare space. This premise was rooted in the fact that CVS has been highly acquisitive, continuous robust growth rate, growing its dividends over time and has an aggressive share buyback program. CVS recently reported robust earnings and continued to drive and position itself for long-term success. With its recent acquisitions and partnerships, specifically, the acquisition Target’s pharmacies and Omnicare will significantly expand its footprint and ability to dispense prescriptions to the general public and in assisted living and long-term care facilities that serve the senior patient population. As the United States continues to absorb an aging population alongside growing overall healthcare costs, more specifically prescription drug costs, CVS looks poised to benefit and continue to outperform the broader market. The most recent earnings report, rise in its 2016 outlook and a 21% boost in its dividend payout underscores this premise. I content that CVS will continue to deliver continued growth and positioning for long-term success. Continue reading "CVS Boosts Dividend By 21% And Raises 2016 Outlook" →

Chevron Flashes Buy

Posted on by Adam Feik

Adam Feik - INO.com Contributor - Energies


You read that headline correctly. Don't look now (you might jinx it), but Chevron Corporation (NYSE:CVX), the large integrated oil major, now sports green monthly and weekly Trade Triangles on its MarketClub chart. And this with oil at $35 per barrel.

CVX has given back about 29% of its value since closing at $134.85 on June 24, 2014 (on a price-only basis). At its worst, the stock's peak-to-trough decline was nearly 47% as of this August 25th, when CVX closed at $70.02. Wednesday's closing price was a much better $93.44 – good for a cool 33% gain for anyone lucky enough to have caught the falling knife right at its recent bottom.

CVX is now down just 12.9% for 2015 year-to-date (YTD) when including dividends. On a 3-year annualized basis, CVX shares have lost 0.6% annualized, and on a 5-year basis, the number is +4.77% per year. All those performance numbers are on par with Exxon Mobil Corp. (NYSE:XOM) and other integrated oil majors. You could safely say it's been a wild ride for all of them. Continue reading "Chevron Flashes Buy" →